Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study

Peré Domingo(Hospital de Sant Pau), Xavier Fulladosa(Bellvitge University Hospital), Rosario Palacios(Bellvitge University Hospital), Hernando Knobel(Hospital General de Granollers), José Ramón Blanco, Antonio Antela(Complejo Hospitalario Universitario de Santiago), Vicente Estrada(Instituto de Salud Carlos III), Ignacio Suárez-Lozano(Universidad de Huelva), Félix Gutiérrez(Universitat de Miguel Hernández d'Elx)

Nefrología

April 24, 2019

10.1016/j.nefro.2019.01.009

Cited by 12

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

|JAMA|2016|1.4k

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

|The Lancet|2019|1k

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19

|JAMA|2021|728

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

|PLoS Medicine|2013|362

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

|The Lancet|2006|343